healthcare News
UroGen surges on Q4 beat, ZUSDURI launch momentum
Biotech beats earnings expectations by 20.9% as bladder cancer treatments drive growth
Sionna falls 3.8% despite earnings beat as losses widen
Cystic fibrosis drugmaker's cash burn raises valuation concerns with mid-2026 catalysts still on the horizon
Merck shares jump 4% on KEYTRUDA-WELIREG trial win in kidney cancer
28% reduction in disease recurrence opens $6 billion market opportunity as Merck plans life after KEYTRUDA patent expiry
Fulgent Genetics plunges 38% on 2026 loss guidance, customer exodus
Largest customer accounting for 22% of revenue transitions testing services in-house, offsetting Q4 earnings beat
CG Oncology surges on strong cash position, accelerated Phase 3 timeline
Biotech reports $903M cash runway into 2029, expedites PIVOT-006 trial results by nearly one year
Amneal surges on earnings beat, returns to profitability
Generic drugmaker raises 2026 guidance after specialty segment drives 38% growth
BrightSpring surges on earnings beat, strong FY26 guidance
Healthcare services provider raises outlook on improving leverage, integration of Amedisys and LHC acquisitions
OrthoPediatrics surges 6% on first positive cash flow, margin expansion
Pediatric orthopedic device maker achieves profitability milestone as Q4 revenue jumps 17% year-over-year